Categories

Brands

Active Ingredient

Warehouses

LGD-4033 (Ligandrol) Information

Click here to view all LGD-4033 (Ligandrol) products
2D Structure of LGD-4033 (Ligandrol)
2D Structure
3D Structure of LGD-4033 (Ligandrol)
3D Structure

LGD-4033, also known as Ligandrol, is a selective androgen receptor modulator (SARM). It was initially developed to treat conditions like muscle wasting and osteoporosis. However, it has gained popularity in the fitness and bodybuilding community due to its potential to enhance muscle growth and performance.

LGD-4033 works by selectively binding to androgen receptors in the body, particularly in the muscles and bones. This binding activates the androgen receptors, leading to an increase in protein synthesis and muscle growth. It also promotes the retention of nitrogen, which is essential for muscle development.

One of the key advantages of LGD-4033 is its selectivity, meaning it primarily targets androgen receptors in muscle and bone tissues, while minimizing potential side effects on other organs like the prostate. This selectivity makes it a safer alternative to traditional anabolic steroids.

Additionally, LGD-4033 has shown potential in improving bone density and strength, which can be beneficial for individuals with conditions like osteoporosis.

It is important to note that LGD-4033 is still under investigation and has not been approved by regulatory bodies for medical use. Its use as a performance-enhancing substance is considered illegal in professional sports. As with any performance-enhancing substance, it is crucial to consult a healthcare professional before considering its use.

Synonyms of LGD-4033 (Ligandrol)

  • 1165910-22-4
  • LGD-4033
  • Ligandrol
  • 4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile
  • LGD4033
  • UNII-1EJT54415A
  • VK-5211
  • 1EJT54415A
  • 4-[(2R)-2-[(1R)-2,2,2-TRIFLUORO-1-HYDROXYETHYL]PYRROLIDIN-1-YL]-2-(TRIFLUOROMETHYL)BENZONITRILE
  • 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile
  • 4-((2R)-2-((1R)-2,2,2-TRIFLUORO-1-HYDROXYETHYL)-1-PYRROLIDINYL)-2-(TRIFLUOROMETHYL)BENZONITRILE
  • 4-((2R)-2-((1R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benZonitrile
  • 4-{(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl}-2-(trifluoromethyl)benzonitrile
  • BENZONITRILE, 4-((2R)-2-((1R)-2,2,2-TRIFLUORO-1-HYDROXYETHYL)-1-PYRROLIDINYL)-2-(TRIFLUOROMETHYL)-
  • Benzonitrile, 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)-
  • LIGANDROL;LGD-4033
  • SCHEMBL221159
  • LIGANDROL [NFLIS-DRUG]
  • LGD4033(LG)
  • Vk5211
  • DTXSID10657620
  • EX-A729
  • VK 5211 [WHO-DD]
  • BCP07128
  • LGD-4033LGD-4033
  • MFCD27923016
  • s8822
  • AKOS022173564
  • CS-4667
  • DB13934
  • LGD-4033(VK-5211)
  • AC-30218
  • HY-13981
  • A14346
  • J-690039
  • Q21098841

External Sources about LGD-4033 (Ligandrol)

Click here to view all LGD-4033 (Ligandrol) products